3 unknown. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
| Phase 3 | 1 | Unknown 1 |
Follow Yang Yang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies Fludarabine, Cyclophosphamide, Interleukin-2 - Stage IV Gastric Carcinoma, Stage IV Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | Unknown | Yang Yang | 20 | 2017-04-07 | 2017-05-02 |
| Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis pulsed low dose rate radiation therapy - Radiotherapy, Radiotherapy Side Effect | Not applicable | Unknown | Yang Yang | 40 | 2017-03-01 | 2017-06-14 |
| Mesenchymal Stem Cells Transplantation for Ischemic-type Biliary Lesions huc-MSCs, Placebo - Ischemic-type Biliary Lesions | Phase 2 / Phase 3 | Unknown | Yang Yang | 66 | 2014-07-01 | 2014-08-22 |
Stomach Neoplasms (2) · Hodgkin Disease (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell (1) · Nasopharyngeal Carcinoma (1) · Radiation Injuries (1)
Cyclophosphamide (1) · Heart Rate (1) · Interleukin-2 (1) · Saline Solution (1) · fludarabine (1) · fludarabine phosphate (1)
China (3)
Baorui Liu, MD (1)